Clinical trials
1 active trial worldwide
Recruiting, about to start, or running now.
- FEAST Perinatal Support Program Intervention NCT06715787
Global Insulin Access Public Health Report: Need and Coverage, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook
| Country | Diabetes (adults, WHO)of adults | Health spending from abroadof health spending |
|---|---|---|
| 17.9% 2022 | 3.5% 2023 | |
| 27.8% 2022 | 3.5% 2023 | |
| 22.6% 2022 | 2.4% 2023 | |
| 12.8% 2022 | 0.6% 2023 | |
| 5.6% 2022 | 20.1% 2023 | |
| 10.9% 2022 | 11.3% 2023 | |
| 30.9% 2022 | 9.7% 2023 | |
| 20.8% 2022 | 0.0% 2023 | |
| 13.9% 2022 | 2.1% 2023 |
Sources: World Health Organization, World Bank. A dash means no recent published figure.
Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.
| Topic | Insulin Access |
|---|---|
| Place | Global |
| Diabetes (adults) (latest) | 14.1% of adults (2022)Source: WHO Global Health Observatory, Diabetes (adults, WHO) (% of adults). Retrieved 20 Nov 2026. |
| Report sections | 16 (table of contents) |
| Active clinical trials | 1 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Many people who need insulin in low- and middle-income countries cannot get or afford it, a century after its discovery. This report covers human insulin, analogue insulin and insulin delivery supplies.
The report sets out the scale of need for insulin access worldwide: who needs it, how many are reached and the health problems it addresses, using Prevalence, Premature NCD Deaths (Ages 30–70), Diagnosis and Control Rates, Risk Factor Levels and Access to Essential Medicines.
Need and coverage are broken down by age (adults 18–39 years, adults 40–59 years, adults 60 years and over and children and adolescents), gender and income, with a focus on older adults, low-income urban residents, rural populations, people with multiple conditions, women and migrant workers.
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Main risk factors include tobacco use, unhealthy diet, physical inactivity, harmful use of alcohol, air pollution and ageing. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
The report reviews awareness and uptake of insulin access, and how people in need are found, through screening in primary care, population screening programmes, risk factor surveys and early detection tests, by group and by area.
It compares the number of people who need insulin access with the number reached, to show the coverage gap and which groups are missed.
Treatment and prevention covered include WHO prequalification of insulin, pooled procurement, biosimilar insulin and free insulin for children, with how widely each is delivered and how well it is sustained.
Health outcomes covered include premature death, disability, catastrophic health costs and multiple long-term conditions, and what is known about the effect of insulin access on them.
The report looks at primary care clinics, specialist centres, diagnostics and laboratories and medicine supply, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).[2] People pay 17.3% of all health spending out of their own pockets (2023).[3] ClinicalTrials.gov lists 1 study on Insulin Access that is recruiting, active or about to start worldwide.[4]
[1] World Health Organization, universal health coverage. Checked 14 Nov 2026.
[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 21 Nov 2026.
[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 20 Nov 2026.
[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
It describes what insulin access costs to deliver, who pays for it and the costs that fall on households, including funding from government, donors and NGOs.
Worldwide guidance and funding for insulin access include WHO Global Action Plan for the Prevention and Control of NCDs, WHO Best Buys for NCDs, WHO HEARTS Technical Package and UN High-Level Meetings on NCDs. The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
It looks ahead at future need for insulin access, the resources it will require and the areas most at risk of falling behind.
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO STEPS Surveys, WHO Global Health Observatory, Global Burden of Disease (IHME), GLOBOCAN Cancer Estimates (IARC) and National Health Surveys. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
What doctors and scientists are doing in Insulin Access Public Health Report right now, from free public sources.
1 active trial worldwide
Recruiting, about to start, or running now.
14.1 % of adults
Diabetes (adults), World, 2022 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Global · 6 shared keywords
Pharmaceuticals · Global
Medical Devices · Global
Medical Devices · Global
Medical Devices · Global
Healthcare Services · Global
Digital Health · Global